praxismedicines.com (PRAX) - Kewajiban jangka dawa marang modal

Praxis Precision Medicines - logo grafis emiten PRAX

Geopolitical instability is disrupting the component logistics for neurotherapy, while sanctions are limiting testing across several regions. This price action for Praxis Precision Medicines (PRAX) on the GURU.Markets platform captured the 0.00 metric. Praxis Precision Medicines (PRAX) relies on a diversified portfolio of mental disorder medications to minimize the risk of failure, while patent protection and strict FDA requirements ensure the exclusivity of its innovations in the field.

Praxis Precision Medicines Inc (PRAX): Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 31.10.2026
Produk asli Praxis Corp

It is critically important for Praxis Precision Medicines (PRAX) to balance the attraction of debt capital against the risks of clinical trial failures. Analyzing the share of long-term loans relative to equity allows for an assessment of the degree of financial leverage by measuring the ratio of liabilities with a maturity of over one year to net assets, which determines the company's resilience to liquidity shortages during prolonged development periods.

Pesaing wigati

Rasio utang jangka dawa marang modal BIIB (Biogen Inc)|Utang jangka dawa marang modal NBIX|RGC - Kewajiban jangka dawa marang modal|Axsome Therapeutics - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal acadia-pharm.com ACAD|XENE - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Catalyst Corp (CPRX)|Utang jangka dawa marang ekuitas Denali Therapeutics|harmonybiosciences.com - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas Biohaven (BHVN)|AMLX (Amylyx Pharmaceuticals Inc) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal TRVI (Trevi Pharma)|Utang jangka dawa marang modal Anavex Life Sciences Corp AVXL|CBLL: Rasio utang jangka dawa marang ekuitas|PRTA (Prothena Corporation PLC) - Rasio utang jangka dawa marang modal|ALEC: Utang jangka dawa marang modal|ANNX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Omeros Corp|Neurogene Therapeutics (NGNE) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas ACIU (AC Immune)|VYGR (voyagertherapeutics.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Neumora Therapeutics, Inc. NMRA|SCLX (Scilex Holding) - Kewajiban jangka dawa marang ekuitas|TVGN - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal ACOG (Alpha Cognition)|CGTX: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal inhibikase.com (IKT)|SAVA (Cassava Sciences) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Assertio Therapeutics (ASRT)|Utang jangka dawa marang modal COYA|Rasio tanggungan utang jangka dawa marang modal vistagen.com|Utang jangka dawa marang ekuitas Ovid Therapeutics OVID|Rasio tanggungan utang jangka dawa marang modal acumenpharm.com (ABOS)|CervoMed - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Alterity Therapeutics ATHE|clene.com (CLNN) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal PepGen (PEPG)|Utang jangka dawa marang ekuitas Jupiter Neurosciences Inc|Rasio utang jangka dawa marang modal RLMD (relmada.com)|Rasio utang jangka dawa marang ekuitas ANVS (Annovis Bio)|GRCE (gracetx.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Firefly Neuroscience Inc AIFF|KLTO - Rasio utang jangka dawa marang ekuitas|NeuroSense Therapeutics, Ltd. - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal revivapharma.com|MTVA: Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal NRXS|HSDT (Helius Medical Technologies, Inc.) - Utang jangka dawa marang modal|Passage Bio Corp (PASG) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang modal NEUP|Rasio utang jangka dawa marang ekuitas minervaneurosciences.com NERV|Utang jangka dawa marang modal ATHA (Athira Pharma)|Rasio tanggungan utang jangka dawa marang modal Addex Therapeutics Ltd. (ADXN)|ALZN - Utang jangka dawa marang ekuitas|CYCN (Cyclerion Therapeutics) - Rasio utang jangka dawa marang modal|PTIX: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Pasithea Therapeutics Corp. (KTTA)|Utang jangka dawa marang ekuitas Cortigent Inc|Avenue Therapeutics Inc. (ATXI) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA: Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas Chromocell Therapeutics CHRO|Koefisien utang jangka dawa marang modal ELYM|Intra-Cellular - Utang jangka dawa marang modal|LBPH - Utang jangka dawa marang modal|MRNS (Marinus) - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal NKGN|Utang jangka dawa marang ekuitas NeuroBo Pharmaceuticals|Rasio utang jangka dawa marang modal SAGE (sagerx.com)|Utang jangka dawa marang modal SNPX|TRVN - Kewajiban jangka dawa marang modal|Vigil Neuroscience, Inc. - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal Anew Medical Inc. WENA|CERE - Utang jangka dawa marang ekuitas